AllianceBernstein’s Palisade Bio PALI Stock Holding History

AllianceBernstein’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Buy	+52,040	New	+$102K	﹤0.01%	3247
2015 Q2	–	Hold	0	–	-$63K	–	3195
2015 Q1	–	Hold	0	–	–	–	3109
2014 Q4	–	Hold	0	–	–	–	3119
2014 Q3	–	Hold	0	–	–	–	3045
2014 Q2	–	Hold	0	–	–	–	3039
2014 Q1	–	Hold	0	–	–	–	3441
2013 Q4	–	Hold	0	–	–	–	3355
2013 Q3	–	Hold	0	–	–	–	3376

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AllianceBernstein's PALI Position: Q2 2026 in Review

AllianceBernstein opened a new position in Palisade Bio (PALI) in Q2 2026: 52,040 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #3247 among its holdings.

124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

AllianceBernstein held 52,040 shares of Palisade Bio worth $109K as of Q2 2026.
Palisade Bio was a new AllianceBernstein position in Q2 2026.
Palisade Bio made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3247 holding.
124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.